Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PELE IDE Clinical Study, Peripheral Onyx™ Liquid Embolic Safety and Effectiveness of The Onyx™ LES for Embolization of Arterial Hemorrhage in the Peripheral Vasculature

NCT06742801 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.

NCT NCT06742801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06742801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PELE IDE Clinical Study, Peripheral Onyx™ Liquid Embolic Safety and Effectiveness of The Onyx™ LES for Embolization of Arterial Hemorrhage in the Peripheral Vasculature
Lead sponsor
Medtronic Endovascular
Phase
Not applicable
Overall status
Recruiting
Start date
May 9, 2025
Completion date
May 31, 2027
Enrollment
119 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

gi bleed, hemorrhage, peripheral arterial hemorrhage, trauma, ulcer